Cargando…
Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity
Both α-Synuclein (αSyn) accumulation and mitochondrial dysfunction have been implicated in the pathology of Parkinson’s disease (PD). Although studies suggest that αSyn and its missense mutant, A53T, preferentially accumulate in the mitochondria, the mechanisms by which αSyn and mitochondrial protei...
Autores principales: | Hu, Di, Sun, Xiaoyan, Liao, Xudong, Zhang, Xinwen, Zarabi, Sara, Schimmer, Aaron, Hong, Yuning, Ford, Christopher, Luo, Yu, Qi, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531426/ https://www.ncbi.nlm.nih.gov/pubmed/30877431 http://dx.doi.org/10.1007/s00401-019-01993-2 |
Ejemplares similares
-
Mitochondrial ClpP serine protease-biological function and emerging target for cancer therapy
por: Nouri, Kazem, et al.
Publicado: (2020) -
Mitochondrial Protease ClpP is a Target for the Anticancer
Compounds ONC201 and Related Analogues
por: Graves, Paul R., et al.
Publicado: (2019) -
Characterization of TR‐107, a novel chemical activator of the human mitochondrial protease ClpP
por: Fennell, Emily M. J., et al.
Publicado: (2022) -
ClpP Protease, a Promising Antimicrobial Target
por: Moreno-Cinos, Carlos, et al.
Publicado: (2019) -
Correction to
“Mitochondrial Protease ClpP
Is a Target for the Anticancer Compounds ONC201 and Related Analogues”
por: Graves, Paul R., et al.
Publicado: (2022)